A facile method for preparing biodegradable chitosan derivatives with low grafting degree of poly(lactic acid)

Dopamine / Artesunate loaded polyhydroxybutyrate-g-cellulose- magnetite zinc oxide core shell nanocomposites: Synergistic antimicrobial and anticancer efficacy

In this study, polyhydroxybutyrate-g-cellulose - Fe3O4/ZnO (PHB-g-cell- Fe3O4/ZnO) nanocomposites (NCs) was synthesized and used as a delivery system for Dopamine (DO) /Artesunate (ART) drugs. Different types of cells (Ccell, Scell, Pcell) grafted with PHB were designed and mixed with different contents of Fe3O4/ZnO. Physical and chemical features of PHB-g-cell-Fe3O4/ZnO NCs were detected by FTIR, XRD, dynamic light scattering, transmission electron microscopy, and scanning electron microscopy. ART/DO drugs were loaded into PHB-g-cell- Fe3O4/ZnO NCs by single emulsion technique. The rate of drugs release was studied at different pHs (5.4, 7.4). Owing to the overlap between the absorption bands of both drugs, differential pulse adsorptive cathodic stripping voltammetry (DP-AdCSV) was used for the estimation of ART. To study the mechanism of ART and DO release, zero-order, first order, Hixon Crowell, Higuchi and Korsmeyer-Peppas models were applied to the experiment results. The results showed that Ic50 of ART @PHB-g-Ccell-10% DO@ Fe3O4/ZnO, ART @PHB-g-Pcell-10% DO@ Fe3O4/ZnO and ART @PHB-g-Scell-10% DO@ Fe3O4/ZnO were 21.22, 12.3, and 18.11 μg/mL, respectively. The results revealed that ART @PHB-g-Pcell-10% DO@ Fe3O4/ZnO was more effective against HCT-116 than the carriers loaded by a single drug. The antimicrobial efficacy of the nano-loaded drugs was considerably improved compared with free drugs.

Development and Characterization of Functional Polylactic Acid/Chitosan Porous Scaffolds for Bone Tissue Engineering

In this study, we developed and characterized various open-cell composite scaffolds for bone regeneration. These scaffolds were made from Polylactic acid (PLA) as the scaffold matrix biopolymeric phase, and chitosan (CS) and chitosan-grafted-PLA (CS-g-PLA) copolymer as the dispersed biopolymeric phase. As a first step, successful grafting of PLA onto CS backbone was executed and confirmed by both FTIR and XPS. Mechanical characterization confirmed that adding CS or CS-g-PLA to the intrinsically rigid PLA made their corresponding PLA/CS and PLA/CS-g-PLA composite scaffolds more flexible under compression. This flexibility was higher for the latter due to the improved compatibility between PLA and CS-g-PLA copolymer. The hydrolytic stability of both PLA/CS and PLA/CS-g-PLA composite scaffolds inside phosphate-buffered saline (PBS) solution, as well as MG-63 osteoblast cell adhesion and proliferation inside both scaffolds, were characterized. The corresponding results revealed that PLA/CS composite scaffolds showed hydrolytic degradation due to the cationic properties of CS. However, modified PLA/CS-g-PLA scaffolds were hydrolytically stable due to the improved interfacial adhesion between the PLA matrix and CS-g-PLA copolymer. Finally, biological characterization was done for both PLA/CS and PLA/CS-g-PLA composite scaffolds. Contrarily to what was observed for uncompatibilized PLA/CS scaffolds, compatibilized PLA/CS-g-PLA scaffolds showed a high MG-63 osteoblast cell proliferation after three and five days of cell culture. Moreover, it was observed that cell proliferation increased with CS-g-PLA content. This suggests that the PLA/CS-g-PLA composite scaffolds could be a potential solution for bone regeneration.

Biodegradable Chitosan-graft-Poly(l-lactide) Copolymers For Bone Tissue Engineering

The design and synthesis of new biomaterials with adjustable physicochemical and biological properties for tissue engineering applications have attracted great interest. In this work, chitosan-graft-poly(l-lactide) (CS-g-PLLA) copolymers were prepared by chemically binding poly(l-lactide) (PLLA) chains along chitosan (CS) via the "grafting to" approach to obtain hybrid biomaterials that present enhanced mechanical stability, due to the presence of PLLA, and high bioactivity, conferred by CS. Two graft copolymers were prepared, CS-g-PLLA(80/20) and CS-g-PLLA(50/50), containing 82 wt % and 55 wt % CS, respectively. Degradation studies of compressed discs of the copolymers showed that the degradation rate increased with the CS content of the copolymer. Nanomechanical studies in the dry state indicated that the copolymer with the higher CS content had larger Young modulus, reduced modulus and hardness values, whereas the moduli and hardness decreased rapidly following immersion of the copolymer discs in alpha-MEM cell culture medium for 24 h. Finally, the bioactivity of the hybrid copolymers was evaluated in the adhesion and growth of MC3T3-E1 pre-osteoblastic cells. In vitro studies showed that MC3T3-E1 cells exhibited strong adhesion on both CS-g-PLLA graft copolymer films from the first day in cell culture, whereas the copolymer with the higher PLLA content, CS-g-PLLA(50/50), supported higher cell growth.

PLA architectures: the role of branching

Biobased and biodegradable polymers have become more and more interesting in view of waste management and crude oil depletion.

Antimicrobial activity of chitosan derivatives containing N-quaternized moieties in its backbone: a review

Chitosan, which is derived from a deacetylation reaction of chitin, has attractive antimicrobial activity. However, chitosan applications as a biocide are only effective in acidic medium due to its low solubility in neutral and basic conditions. Also, the positive charges carried by the protonated amine groups of chitosan (in acidic conditions) that are the driving force for its solubilization are also associated with its antimicrobial activity. Therefore, chemical modifications of chitosan are required to enhance its solubility and broaden the spectrum of its applications, including as biocide. Quaternization on the nitrogen atom of chitosan is the most used route to render water-soluble chitosan-derivatives, especially at physiological pH conditions. Recent reports in the literature demonstrate that such chitosan-derivatives present excellent antimicrobial activity due to permanent positive charge on nitrogen atoms side-bonded to the polymer backbone. This review presents some relevant work regarding the use of quaternized chitosan-derivatives obtained by different synthetic paths in applications as antimicrobial agents.

Fabrication and characterization of heparin-grafted poly-L-lactic acid-chitosan core-shell nanofibers scaffold for vascular gasket

Electrospun nanofibers were widely studied to be applied as potential materials for tissue engineering. A new technology to make poly-l-lactic acid/chitosan core/shell nanofibers from heterologous solution by coaxial electrospinning technique was designed for vascular gasket. Chitosan surface was cross-linked by genipin and modified by heparin. Different ratios of PLA/CS in heterologous solution were studied to optimize the surface morphology of fibers. Clean core-shell structures formed with a PLA/CS ratio at 1:3. Superior biocompatibility and mechanical properties were obtained by optimizing the core-shell structure morphology and surface cross-linking of chitosan. UE7T-13 cells grew well on the core-shell structure fibers as indicated by methylthiazolyldiphenyl-tetrazolium bromide (MTT) results and scanning electron microscopy (SEM) images. Compared with the pure PLA fiber meshes and commercial vascular patch, PLA/CS core-shell fibers had better mechanical strength. The elastic modulus was as high as 117.18 MPa, even though the yield stress of the fibers was lower than that of the commercial vascular patch. Attachment of red blood cell on the fibers was evaluated by blood anticoagulation experiments and in vitro blood flow experiments. The activated partial thromboplastin time (APTT) and prothrombin time (PT) value from PLA/CS nanofibers were significantly longer than that of pure PLA fibers. SEM images indicated there were hardly any red blood cells attached to the fibers with chitosan coating and heparin modification. This type of fiber mesh could potentially be used as vascular gasket.

Preparation of biocompatible chitosan grafted poly(lactic acid) nanoparticles

Chitosan grafted poly(lactic acid) (CS-g-PLA) copolymer was synthesized and characterized by FT-IR and elemental analysis. The degree of poly(lactic acid) substitution on chitosan was 1.90 ± 0.04%. The critical aggregation concentration of CS-g-PLA in distilled water was 0.17 mg/ml. Three methods of preparing CS-g-PLA nanoparticles (diafiltration method, ultrasonication method and diafiltration combined with ultrasonication method) were investigated and their effect was compared. Of the three methods, diafiltration combined with ultrasonication method produced nanoparticles with optimal property in terms of size and morphology, with size ranging from 133 to 352 nm and zeta potential from 36 to 43 mV. Also, the hemolytic activity and cytotoxicity of the CS-g-PLA based nanoparticles was tested, and results showed low hemolysis rate (<5%) and no significant cytotoxicity effect of these nanoparticles.